Fair value, page-42

What particular test might that be? Efficacy is usually measured by the reduction in viral load and a statistical representation that this is achieved because of the treatment. So, my question still has not been answered. What will constitute efficacy to the extent that partners will be lining up to offer us deals?

What happens if that level of efficacy is not met with the current trial? What impact will that result have on our ability to raise additional capital?